[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-25 20:44:28 UTC

$ATAI -XXXXX% After Hours | Phase 2b Miss for Inidascamine | via

• $ATAI plunged after its Phase 2b trial for Inidascamine in treating CIAS (cognitive impairment associated with schizophrenia) failed to meet the primary endpoint.
• Despite the miss, the drug showed modest, consistent numerical improvements in cognitive and functional measures.
• Safety profile was favorable — no sedation, weight gain, or extrapyramidal symptoms reported.
• The setback raises concerns over clinical efficacy but leaves room for further exploration given safety signals.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948846837827350960/c:line.svg)

**Related Topics**
[$atai](/topic/$atai)
[atai life](/topic/atai-life)
[stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries)

[Post Link](https://x.com/overnight_stock/status/1948846837827350960)